HBIO
Harvard Bioscience Inc
Price:  
3.30 
USD
Volume:  
87,398.00
United States | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HBIO WACC - Weighted Average Cost of Capital

The WACC of Harvard Bioscience Inc (HBIO) is 8.6%.

The Cost of Equity of Harvard Bioscience Inc (HBIO) is 9.30%.
The Cost of Debt of Harvard Bioscience Inc (HBIO) is 6.65%.

Range Selected
Cost of equity 6.80% - 11.80% 9.30%
Tax rate 11.50% - 22.20% 16.85%
Cost of debt 6.30% - 7.00% 6.65%
WACC 6.6% - 10.5% 8.6%
WACC

HBIO WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.64 1.24
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.80% 11.80%
Tax rate 11.50% 22.20%
Debt/Equity ratio 0.25 0.25
Cost of debt 6.30% 7.00%
After-tax WACC 6.6% 10.5%
Selected WACC 8.6%